Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI- and PET-Predictive-Assay of Treatment Outcome in Cancer of the Cervix

NCT01992861 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01992861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01992861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI- and PET-Predictive-Assay of Treatment Outcome in Cancer of the Cervix
Lead sponsor
University of Washington
Phase
Observational
Overall status
Terminated
Start date
February 14, 2014
Completion date
January 31, 2022
Enrollment
51 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenocarcinoma, cervical adenosquamous carcinoma, cervical squamous cell carcinoma, not otherwise specified, cervical undifferentiated carcinoma, recurrent cervical carcinoma, stage ib2 cervical cancer, stage ii cervical cancer, stage iia cervical cancer, stage iib cervical cancer, stage iii cervical cancer, stage iiia cervical cancer, stage iiib cervical cancer, stage iva cervical cancer